Pneumococcal conjugate vaccines probe studies: The solution points to the problem

Advances in Experimental Medicine and Biology

Volumn 634, Issue , 2009, Pages 69-77

  Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PLACEBO; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CARRIER; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; HERD IMMUNITY; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; INCIDENCE; LOBAR PNEUMONIA; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROGNOSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

EID: 84934437638     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-79838-7_7     Document Type: Article

References (21)

1. Bryce, J., Boschi-Pinto, C., Shibuya, K. and Black, R. E. (2005). WHO estimates of the causes of death in children. The Lancet, 365, 1147-1152. (Pubitemid 40417564)
2. Buttery, J. P., Riddell, A., McVernon, J., Chantler, T., Lane, L., Bowen-Morris, J., Diggle, L., Morris, R., Harnden, A., Lockhart, S., Pollard, A. J., Cartwright, K. and Moxon, E. R. (2005). Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. JAMA 293, 1751-1758.
3. CDC. (2005). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR, 54, 893-897.
4. Cherian, T., Mulholland, E. K., Carlin, J. B., Ostensen, H., Amin, R., de Campo, M., Greenberg, D., Lagos, R., Lucero, M., Madhi, S. A., O'Brien, K. L., Obaro, S. and Steinhoff, M. C. (2005). Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ, 83, 353-359. (Pubitemid 40704864)
5. Cutts, F. T., Zaman, S. M., Enwere, G., Jaffar, S., Levine, O. S., Okoko, J. B., Oluwalana, C., Vaughan, A., Obaro, S. K., Leach, A., McAdam, K. P., Biney, E., Saaka, M., Onwuchekwa, U., Yallop, F., Pierce, N. F., Greenwood, B. M. and Adegbola, R. A. (2005). Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. The Lancet, 365, 365-1146.
6. Dagan, R., Givon-Lavi, N., Abu-Abed, J., Rosenblum, H. and Greenberg, D. (2007). Nasopharyngeal pneumococcal carriage in first year of life following administration of two or three doses of 7-valent CRM-conjugate vaccine [G-1241]. 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17-20, 2007, Chicago, IL.
7. Dagan, R., Sikuler-Cohen, M., Zamir, O., Janco, J., Givon-Lavi, N. and Fraser, D. (2001). Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr. Infect. Dis. J., 20, 20-958.
8. Fireman, B., Black, S. B., Shinefield, H. R., Lee, J., Lewis, E. and Ray, P. (2003). Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr. Infect. Dis. J. 22, 22-16.
9. Goldblatt, D., Southern, J., Ashton, L., Richmond, P., Burbidge, P., Tasevska, J., Crowley-Luke, A., Andrews, N., Morris, R., Borrow, R., Cartwright, K. and Miller, E. (2006). Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr. Infect. Dis. J. 25, 25-319.
10. Grijalva, C. G., Nuorti, J. P., Arbogast, P. G., Martin, S. W., Edwards, K. M. and Griffin, M. R. (2007). Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369, 369-1186.
11. Hicks, L. A., Harrison, L. H., Flannery, B., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D., Thomas, A., Beall, B., Lynfield, R., Reingold, A., Farley, M. M. and Whitney, C. G. (2007). Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998-2004. J. Infect. Dis. 196, 196-1354.
12. Lexau, C. A., Lynfield, R., Danila, R., Pilishvili, T., Facklam, R., Farley, M. M., Harrison, L. H., Schaffner, W., Reingold, A., Bennett, N. M., Hadler, J., Cieslak, P. R. and Whitney, C. G. (2005). Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294, 294-2051.
13. Lockhart, S. P., Hackell, J. G. and Fritzell, B. (2006). Pneumococcal conjugate vaccines: emerging clinical information and its implications. Expert Rev. Vaccines, 5, 5-564.
14. Madhi, S. A. and Klugman, K. P. (2007). World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines. Vaccine 25, 25-2419.
15. Madhi, S. A., Klugman, K. P. and The Vaccine Trialist, G. (2004). A role for Streptococcus pnemoniae in virus-associated pneumonia. Nat. Med. 10, 10-813.
16. Madhi, S. A., Kuwanda, L., Cutland, C. and Klugman, K. P. (2005). The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and-uninfected children. Clin. Infect. Dis. 40, 40-1518.
17. Madhi, S. A., Ludewick, H., Kuwanda, L., Niekerk, N., Cutland, C., Little, T. and Klugman, K. P. (2006). Pneumococcal coinfection with human metapneumovirus. J. Infect. Dis. 193, 193-1243.
18. Rudan, I., Tomaskovic, L., Boschi-Pinto, C. and Campbell, H. (2004). Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull. World Health Organ. 82, 82-903.
19. Salt, P., Banner, C., Oh, S., Yu, L. M., Lewis, S., Pan, D., Griffiths, D., Ferry, B. and Pollard, A. (2007). Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood. Clin. Vaccine Immunol. 14, 14-599.
20. Veenhoven, R., Bogaert, D., Uiterwaal, C., Brouwer, C., Kiezebrink, H., Bruin, J., lJzerman, E., Hermans, P., de Groot, R., Zegers, B., Kuis, W., Rijkers, G., Schilder, A. and Sanders, E. (2003). Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomized study. The Lancet, 361, 361-2195.
21. Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., Facklam, R. R., Jorgensen, J. H. and Schuchat, A. (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 348-1746.